Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 study of an investigational antiparkinsonian agent vs pramipexole in Parkinson's disease
jRCT2080224565Phase 2Completed
- Sponsor
- Kissei Pharmaceutical Co., Ltd.
- Start
- Feb 2019
- Countries
- 1
01
Overview
Phase 2 trial in Parkinson's disease (PD) (2 arms), sponsored by Kissei Pharmaceutical Co., Ltd. Started Feb 2019; status: completed.
02
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on jRCT2080224565.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080224565.